REGN Insider Trading Activity and SEC Form 4 Filings
Trump's trades in REGN
From his financial disclosures
$184K+
8 purchases
$102K+
3 sales
Purchase
Jul 23, 2026
Reported 61d later
$50K - $100K
Purchase
Jul 17, 2026
Reported 67d later
$1K - $15K
Sale
Jun 16, 2026
Reported 67d later
$1K - $15K
Sale
Jun 12, 2026
Reported 71d later
$100K - $250K
Sale
May 18, 2026
Reported 44d later
$1K - $15K
Purchase
May 11, 2026
Reported 51d later
$100K - $250K
Many orders in these accounts are placed by the account manager. See all 11 trades
REGN insider trading summary
Over the past 12 months, insiders at Regeneron Pharmaceuticals, Inc. (REGN) reported 99 sales worth $56.5M by 11 insiders and no open-market purchases on SEC Form 4. Net insider selling was $56.5M.
Latest REGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $33K (35 @ $945.61) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $499K (529 @ $943.53) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $1.1M (1,215 @ $942.31) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $102K (108 @ $944.22) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $412K (439 @ $939.57) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $170K (179 @ $950.76) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $925K (982 @ $941.58) |
| Nov 4, 2026 | Jason Pitofsky | SVP Controller | Sell | $541K (575 @ $940.46) |
| Nov 3, 2026 | Huda Y Zoghbi | Director | Sell | $486K (500 @ $971.06) |
| Nov 3, 2026 | Huda Y Zoghbi | Director | Sell | $6.7M (6,939 @ $970.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.